InMed Pharmaceuticals Inc (INM)

[lesgetrich]

People need to understand that this is a long term investment. Drugs aren't developed and approved overnight. Just look at GW Pharmaceuticals. They've gone to over $100/share based on the promise of delivering an epilepsy drug which has yet to be approved, but it's taken several years. You can't expect a progress report every week.

That said, the potential for this company is huge. What we're seeing is traders flipping and taking profits. Long term investors in this company will see huge rewards over the next two years. For them, this is a great buying opportunity to load up on some cheap shares. The company just sold $5 million worth of their shares at $.33/share (US). Those investment bankers thought the company was a bargain at that price.